https://www.who.int/publications-detail-redirect/9789240060401
0
0
38 words
0
Comments
This meeting, held on 3, 11 and 29 November 2021, reviewed key issues in product development for monoclonal antibodies (mAbs) for malaria prevention
You are the first to view
Create an account or login to join the discussion